Developing a Once-Daily Bilayer Tablet for a 505(b)(2) Clinical

EXTENDED RELEASE TABLET FORMULATION DEVELOPMENT Developing a Once-Daily Bilayer Tablet for a 505(b)(2) Clinical Program How Vici combined immediate- and extended-release APIs in one tablet—and delivered Phase 2 clinical supplies with amended-IND support in approximately six months. Talk to an Expert This representative technical development story is based on pharmaceutical development work completed by Vici […]

Balancing Mouthfeel and Manufacturability in Chewable Tablet Development

CHEWABLE TABLET FORMULATION DEVELOPMENT Balancing Mouthfeel and Manufacturability in Chewable Tablet Development How four rapid prototype-and-tasting cycles solved tablet capping without sacrificing a premium chewing experience. Talk to an Expert This representative technical development story combines lessons from related Vici Health Sciences projects. Certain client, ingredient, formulation, and timeline details have been modified, generalized, combined, […]